The IMpower132 Trial: Does This Change the Advanced NSCLC Landscape? (BMIC-069)
Dec 04, 2018•7 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Dr. Jack West reviews the IMpower132 trial of platinum + pemetrexed with or without atezolizumab as first line treatment for advanced non-squamous NSCLC and where these results fit into management of patients in this setting.
For the best experience, listen in Metacast app for iOS or Android
Open in Metacast